Search research articles
Contact Us
Filters
Showing results (141-150 of 157) with videos related to
Page
of 16
Sort By:
Critical Care Medicine
|
February 1, 1996
Funding resuscitation research
W L Thompson, R Bellamy, R O Cummins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 23, 2012
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women
David I Bernstein, Abbie R Bellamy, Edward W Hook, et al.
JAMA
|
October 8, 2014
Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial
Mark J Mulligan, David I Bernstein, Patricia Winokur, et al.
Southern Medical Journal
|
June 14, 2014
HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women)
Joann M Schulte, Abbie R Bellamy, Edward W Hook, et al.
Vaccines
|
March 19, 2020
Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine
Lilin Lai, Nadine Rouphael, Yongxian Xu, et al.
The Journal of Infectious Diseases
|
February 5, 2015
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old
Wendy A Keitel, Lisa A Jackson, Srilatha Edupuganti, et al.
Vaccine
|
December 15, 2015
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
David I Bernstein, Flor M Munoz, S Todd Callahan, et al.
Critical Care Medicine
|
February 1, 1996
Resuscitation from severe hemorrhage
W C Shoemaker, A B Peitzman, R Bellamy, et al.
Vaccine
|
August 4, 2019
Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents
Flor M Munoz, Evan J Anderson, David I Bernstein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2000
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan
R Bellamy, N Beyers, K P McAdam, et al.
Page
of 16
Search research articles
Search
Showing results (141-150 of 157) with videos related to
Sort By:
Page
of 16
Critical Care Medicine
|
February 1, 1996
Funding resuscitation research
W L Thompson, R Bellamy, R O Cummins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 23, 2012
Epidemiology, clinical presentation, and antibody response to primary infection with herpes simplex virus type 1 and type 2 in young women
David I Bernstein, Abbie R Bellamy, Edward W Hook, et al.
JAMA
|
October 8, 2014
Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial
Mark J Mulligan, David I Bernstein, Patricia Winokur, et al.
Southern Medical Journal
|
June 14, 2014
HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women)
Joann M Schulte, Abbie R Bellamy, Edward W Hook, et al.
Vaccines
|
March 19, 2020
Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine
Lilin Lai, Nadine Rouphael, Yongxian Xu, et al.
The Journal of Infectious Diseases
|
February 5, 2015
Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old
Wendy A Keitel, Lisa A Jackson, Srilatha Edupuganti, et al.
Vaccine
|
December 15, 2015
Safety and efficacy of a cytomegalovirus glycoprotein B (gB) vaccine in adolescent girls: A randomized clinical trial
David I Bernstein, Flor M Munoz, S Todd Callahan, et al.
Critical Care Medicine
|
February 1, 1996
Resuscitation from severe hemorrhage
W C Shoemaker, A B Peitzman, R Bellamy, et al.
Vaccine
|
August 4, 2019
Safety and immunogenicity of unadjuvanted subvirion monovalent inactivated influenza H3N2 variant (H3N2v) vaccine in children and adolescents
Flor M Munoz, Evan J Anderson, David I Bernstein, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 22, 2000
Genetic susceptibility to tuberculosis in Africans: a genome-wide scan
R Bellamy, N Beyers, K P McAdam, et al.
Page
of 16